Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials


PAPR: Psilocybin-assisted Psychotherapy + Mindfulness-Based Stress Reduction (MBSR) for Front-line Healthcare Provider COVID-19 Related Burnout


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05557643

Organisation Name: University of Utah

Overal Status: Not yet recruiting

Start Date: January 1, 2023

Last Update: October 10, 2022

Lead Sponsor: University of Utah

Brief Summary: This project is an open-label randomized study looking at an 8-week Mindfulness-Based Stress Reduction (MBSR) curriculum vs. an 8-week MBSR curriculum + a group psilocybin-assisted psychotherapy intervention for frontline healthcare providers struggling with symptoms of depression and burnout associated with the SARS-CoV-2 pandemic.

Following consenting and enrollment a total of 24 participants will be randomized to receive either an 8-week MBSR curriculum or the same 8-week MBSR curriculum + a group psilocybin-assisted psychotherapy intervention. The group psilocybin-assisted psychotherapy intervention will involve 3 group preparatory sessions (2 hours each), a single 8 hour group psilocybin administration session with a 1:1 therapist to participant ratio (25mg psilocybin dose), and 3 group integration sessions (2 hours each).

Conditions:
  • Depression
  • Burnout, Professional


Total execution time in seconds: 0.34474992752075